Britain is on condition that an additional 50 million pounds ($78 million) to pay for cancer medicines from October, bringing brazen a supervision guarantee to give entrance to drug even if they have not been authorized by price watchdog NICE....
Health News
Roche's blockbuster blight biologic Avastin has been spurned already afresh by Britain's bloom amount babysitter NICE, this time as a analysis for breast cancer....
Health News
Novartis AG's blight biologic Afinitor has been alone for patients with branch blight by Britain's bloom costs watchdog, which says it is too cher for the country's taxpayer-funded National Bloom Service (NHS)....
Health News
Glivec, from Novartis, should not be acclimated in patients who accept had a gastrointestinal stromal bump (GIST) removed by surgery, Britain's bloom amount babysitter said in abstract advice on Friday....
Health News
GlaxoSmithKline leukemia biologic Arzerra, accountant from Denmark's Genmab, has been alone by Britain's amount babysitter NICE in basic abstract guidance....